
Jocelyn Ulrich Jocelyn Ulrich, MPH, is Deputy Vice President, Policy and Research, at the Pharmaceutical Research and Manufacturers of America (PhRMA). At PhRMA, she is responsible for developing legislative and policy analysis and research studies on a range of issues impacting innovative biopharmaceutical companies including intellectual property issues, FDA policy issues, the R&D process, the value of innovation, and other issue areas impacting the environment for innovation. In addition to her experience at PhRMA she has over 15 years of experience in the pharmaceutical industry at Pfizer, Human Genome Sciences, and EMD Serono in roles in clinical research management, investigator-initiated and collaborative research, and global policy and corporate affairs. Jocelyn holds an MPH in global health policy and management from New York University.
Recent Posts
ICYMI: Report provides actionable recommendations to strengthen America’s preparedness and future health crises response

New Graphic: Public-Private collaboration fuels the U.S. biopharmaceutical ecosystem

R&D Focus: 5 things to know about the biopharmaceutical research ecosystem

Clinical Trials Q&A: A patient’s perspective

Clinical Trials Q&A: Examining clinical trial design

Clinical Trials Q&A: Income disparities

BMJ clinical trial report misleading

Clinical Trials Q&A: Improving the recruitment process by listening to patients

Clinical Trials Q&A : How does collaboration increase clinical trial awareness and access?

Introducing clinical research participation to the everyday person
